EUVIMEDEUVIMED entdecken
Crossref

Clinical Outcomes in Patients With Krukenberg Tumors From Colorectal Cancer

Arsha Ostowari, Bima J Hasjim, Leena Lim, Jingjing Yu, Lily Nguyen, Farshid Dayyani, Jason Zell, May Cho, Maheswari Senthil, Oliver S Eng

Journal of Surgical Research · 2024

DOI: 10.1016/j.jss.2024.04.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Research, 2024. Verfasst von Arsha Ostowari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California, Irvine Medical Center, Orange, California. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Krukenberg Tumor, Ovarian Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Ovarian metastases from gastrointestinal cancers such as colorectal cancer, also known as Krukenberg tumors (KTs), present unique challenges in management due to diagnostic uncertainty, decreased responsiveness to systemic therapies compared to other sites of metastasis, and associated debilitating symptomatology. Thus, we sought to characterize our institutional outcomes in metastatic colorectal cancer (mCRC) patients with KTs. METHODS: A retrospective single-institution study was performed identifying adult, female patients from 2012 to 2021 with a diagnosis of mCRC. Patient demographics and clinicopathologic characteristics were collected and analyzed. Descriptive statistics, univariate and multivariable analyses, and Kaplan-Meier survival analyses were performed. RESULTS: Of 235 mCRC patients, 45 (19.1%) had KTs, 41 (91.1%) of whom had KTs in conjunction with other metastatic sites. Other initial sites of metastasis included the liver (n = 93, 39.6%), lung (n = 28, 11.9%), and peritoneum (n = 18, 7.7%). In the KT cohort, the median age was 48 y, 53.3% were non-Hispanic White, 100% had microsatellite stable tumors, 33.3% had Kristen Rat Sarcoma Virus (KRAS) mutations, and 6.7% had V-raf Murine Sarcoma Viral Oncogene Homolog B (BRAF) mutations. Fifty five point six percent of KT patients underwent cytoreductive surgery (CRS), 24.4% underwent palliative debulking, and 20% underwent no surgical intervention. Reasons for not undergoing CRS were disease-related (n = 14, 70%), due to poor performance status (n = 1, 5%), or both (n = 5, 25%). Five-year overall survival was 48.2% in KT patients who underwent CRS. Poor tumor grade was an independent predictor of mortality (hazard ratio 10.69, 95% confidence interval 1.20-95.47, P = 0.03). CONCLUSIONS: Almost 90% of our patient cohort with KTs from mCRC experience additional sites of metastasis. Around half of KT patients who underwent CRS were alive at 5 y.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsKrukenberg TumorOvarian NeoplasmsHumansFemaleMiddle AgedRetrospective StudiesAdultAgedKaplan-Meier EstimateTreatment OutcomeCytoreduction Surgical ProceduresProto-Oncogene Proteins B-raf

Stichwörter der Autor:innen

Colorectal cancerCytoreductive surgeryKrukenberg tumorsMetastatic colorectal cancer

Substanzen

Proto-Oncogene Proteins B-raf

Autor:innen und Institutionen

  • Department of Surgery, University of California, Irvine Medical Center, Orange, California.
  • Department of Surgery, University of California, Irvine Medical Center, Orange, California; Department of Transplant Surgery, Northwestern University, Chicago, Illinois.
  • University of California Irvine School of Medicine, Irvine, California.
  • Division of Hematology/Oncology, Department of Medicine, University of California, Irvine Medical Center, Orange, California; Chao Comprehensive Cancer Center, University of California, Irvine Medical Center, Orange, Ca…
  • Chao Comprehensive Cancer Center, University of California, Irvine Medical Center, Orange, California; Division of Surgical Oncology, Department of Surgery, University of California, Irvine Medical Center, Orange, Calif…

Zitieren

APA

Ostowari, A., Hasjim, B. J., Lim, L., Yu, J., Nguyen, L., Dayyani, F., Zell, J., Cho, M., Senthil, M., & Eng, O. S. (2024). Clinical Outcomes in Patients With Krukenberg Tumors From Colorectal Cancer. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2024.04.030

Vancouver

Ostowari A, Hasjim BJ, Lim L, Yu J, Nguyen L, Dayyani F, et al. Clinical Outcomes in Patients With Krukenberg Tumors From Colorectal Cancer. Journal of Surgical Research. 2024. doi:10.1016/j.jss.2024.04.030

BibTeX
@article{Ostowari2024,
  author = {Ostowari, Arsha and Hasjim, Bima J and Lim, Leena and Yu, Jingjing and Nguyen, Lily and Dayyani, Farshid and Zell, Jason and Cho, May and Senthil, Maheswari and Eng, Oliver S},
  title = {Clinical Outcomes in Patients With Krukenberg Tumors From Colorectal Cancer},
  journal = {Journal of Surgical Research},
  year = {2024},
  doi = {10.1016/j.jss.2024.04.030}
}
Kostenlos starten →